Literature DB >> 18937113

Cytokines in Alzheimer's disease and vascular dementia.

P Angelopoulos1, H Agouridaki, H Vaiopoulos, E Siskou, K Doutsou, V Costa, S I Baloyiannis.   

Abstract

The levels of interleukin 1beta, interleukin 6, and interleukin 10 were elevated in the serum of patients with dementia. No statistically significant correlation was recorded in the interleukin levels among patients with Alzheimer's disease and vascular dementia. Also, no significant correlation was observed in the interleukin levels in the serum and the severity of dementia. However, a significant correlation was found between IL-6 and tumor necrosis factor-alpha (TNF-alpha) levels and age. The levels of IL-1beta and IL-6 were positively correlated with hypertension, and IL-2 levels were negatively correlated. No correlation was found between depressive symptoms and levels of cytokines in the serum.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18937113     DOI: 10.1080/00207450701392068

Source DB:  PubMed          Journal:  Int J Neurosci        ISSN: 0020-7454            Impact factor:   2.292


  27 in total

1.  Valproic acid alleviates memory deficits and attenuates amyloid-β deposition in transgenic mouse model of Alzheimer's disease.

Authors:  Ai-Guo Xuan; Xue-Bing Pan; Peng Wei; Wei-Dong Ji; Wen-Juan Zhang; Ji-Hong Liu; Le-Peng Hong; Wen-Liang Chen; Da-Hong Long
Journal:  Mol Neurobiol       Date:  2014-05-23       Impact factor: 5.590

2.  Single-Nucleotide Polymorphisms in Interleukin 6 (IL-6) Gene Are Associated with Suicide Behavior in an Iranian Population.

Authors:  Mohammad Mahdi Eftekharian; Rezvan Noroozi; Mir Davood Omrani; Zohreh Sharifi; Alireza Komaki; Mohammad Taheri; Soudeh Ghafouri-Fard
Journal:  J Mol Neurosci       Date:  2018-09-30       Impact factor: 3.444

Review 3.  Let's make microglia great again in neurodegenerative disorders.

Authors:  Marie-Victoire Guillot-Sestier; Terrence Town
Journal:  J Neural Transm (Vienna)       Date:  2017-10-12       Impact factor: 3.575

4.  Association of anti-inflammatory cytokine IL10 polymorphisms with motoric cognitive risk syndrome in an Ashkenazi Jewish population.

Authors:  Sanish Sathyan; Nir Barzilai; Gil Atzmon; Sofiya Milman; Emmeline Ayers; Joe Verghese
Journal:  Neurobiol Aging       Date:  2017-06-19       Impact factor: 4.673

5.  Glial fibrillary acidic protein is one of the key factors underlying neuron-like elongation in PC12 cells.

Authors:  Maki Sugaya-Fukasawa; Toru Watanabe; Michiko Tamura; Satsuki Egashira; Hisashi Hisatomi
Journal:  Exp Ther Med       Date:  2010-11-05       Impact factor: 2.447

6.  Effects of n-3 FA supplementation on the release of proresolving lipid mediators by blood mononuclear cells: the OmegAD study.

Authors:  Xiuzhe Wang; Erik Hjorth; Inger Vedin; Maria Eriksdotter; Yvonne Freund-Levi; Lars-Olof Wahlund; Tommy Cederholm; Jan Palmblad; Marianne Schultzberg
Journal:  J Lipid Res       Date:  2015-01-23       Impact factor: 5.922

7.  Il10 deficiency rebalances innate immunity to mitigate Alzheimer-like pathology.

Authors:  Marie-Victoire Guillot-Sestier; Kevin R Doty; David Gate; Javier Rodriguez; Brian P Leung; Kavon Rezai-Zadeh; Terrence Town
Journal:  Neuron       Date:  2015-01-22       Impact factor: 17.173

Review 8.  The impact of physical activity on blood inflammatory cytokines and neuroprotective factors in individuals with mild cognitive impairment: a systematic review and meta-analysis of randomized-controlled trials.

Authors:  Chuyi Ma; Miaoran Lin; Jiahui Gao; Shurui Xu; Li Huang; Jingfang Zhu; Jia Huang; Jing Tao; Lidian Chen
Journal:  Aging Clin Exp Res       Date:  2022-01-13       Impact factor: 3.636

9.  Sex effects of interleukin-6 deficiency on neuroinflammation in aged C57Bl/6 mice.

Authors:  V M Miller; D A Lawrence; G A Coccaro; T K Mondal; K Andrews; A Dreiem; R F Seegal
Journal:  Brain Res       Date:  2010-01-11       Impact factor: 3.252

Review 10.  Cerebrospinal fluid and blood biomarkers in Alzheimer's disease.

Authors:  Christian Humpel; Tanja Hochstrasser
Journal:  World J Psychiatry       Date:  2011-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.